Moderna (MRNA) EBT Margin Growth (1y) (2018 - 2026)
Moderna (MRNA) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | 54,966.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,966.00 |
| Dec 31, 2025 | 472.00 |
| Sep 30, 2025 | -1,953.00 |
| Jun 30, 2025 | -4,535.00 |
| Mar 31, 2025 | -19,499.00 |
| Dec 31, 2024 | -12,506.00 |
| Sep 30, 2024 | 10,806.00 |
| Jun 30, 2024 | -2,228.00 |
| Mar 31, 2024 | -68,122.00 |
| Dec 31, 2023 | -3,006.00 |
| Sep 30, 2023 | -14,311.00 |
| Jun 30, 2023 | -56,053.00 |
| Mar 31, 2023 | -8,610.00 |
| Dec 31, 2022 | -4,247.00 |
| Sep 30, 2022 | -3,531.00 |
| Jun 30, 2022 | -1,825.00 |
| Mar 31, 2022 | 467.00 |
| Dec 31, 2021 | 12,248.00 |
| Sep 30, 2021 | 21,925.00 |
| Jun 30, 2021 | 24,498.00 |